Miami Herald Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
FDA Grants Tentative Approval To Supernus' Trokendi
By: MarketMinute.com Stock News
Posted on June 26, 2012 at 13:21 PM EDT

The Food and Drug Administration granted tentative approval to Supernus Pharmaceuticals Inc.'s (Nasdaq: SUPN) epilepsy treatment Trokendi XR. The stock price more than doubled by leaping $7.63 to $13.34.



Related Stocks:
SUPERNUS PHARM
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here